Community transmission in the United States of a CTX-M-15-producing sequence type ST131 Escherichia coli strain resulting in death

Journal of Clinical Microbiology

Volumn 49, Issue 9, 2011, Pages 3406-3408

  Owens Jr , Robert C ^a,b   Johnson, James R ^c   Stogsdill, Patricia ^a,b   Yarmus, Lonny ^a,f   Lolans, Karen ^d,e   Quinn, John ^d,e  

^a MAINE MEDICAL CENTER   (United States)

^b UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

^d Chicago Infectious Disease Research Institute   (United States)

^e PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United States)

^f JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; BETA LACTAMASE CTX M; BETA LACTAMASE CTX M 15; CARBAPENEM DERIVATIVE; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; CORTICOSTEROID; COTRIMOXAZOLE; CREATINE KINASE; HYPERTENSIVE AGENT; MEROPENEM; PIPERACILLIN PLUS TAZOBACTAM; QUINOLINE DERIVED ANTIINFECTIVE AGENT; UNCLASSIFIED DRUG;

ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; ARTIFICIAL VENTILATION; BACTERIAL STRAIN; BACTERIAL TRANSMISSION; BACTERIURIA; BLOOD CULTURE; CREATINE KINASE BLOOD LEVEL; CYSTITIS; DEATH; DISEASE EXACERBATION; DYSURIA; ESCHERICHIA COLI; FEVER; FLANK PAIN; HUMAN; HYDRONEPHROSIS; INTENSIVE CARE; LEUKOCYTE COUNT; LEUKOCYTOSIS; MIDDLE AGED; MULTIDRUG RESISTANCE; MULTILOCUS SEQUENCE TYPING; MULTIPLE ORGAN FAILURE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; PYELONEPHRITIS; PYURIA; SEPTIC SHOCK; UNITED STATES; URINARY TRACT INFECTION; URINE CULTURE; UROSEPSIS;

BETA-LACTAMASES; CLUSTER ANALYSIS; COMMUNITY-ACQUIRED INFECTIONS; DNA, BACTERIAL; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ELECTROPHORESIS, GEL, PULSED-FIELD; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FATAL OUTCOME; FEMALE; HUMANS; MIDDLE AGED; MOLECULAR TYPING; SEPSIS; UNITED STATES; URINARY TRACT INFECTIONS;

ESCHERICHIA COLI;

EID: 80052193936     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.00993-11     Document Type: Article

References (14)

1. Colgan, R., J. R. Johnson, M. Kuskowski, and K. Gupta. 2008. Risk factors for trimethoprim-sulfamethoxazole resistance in patients with acute uncomplicated cystitis. Antimicrob. Agents Chemother. 52:846-851.
2. Ender, P. T., et al. 2009. Transmission of extended-spectrum beta-lactamase-producing Escherichia coli (sequence type ST131) between a father and daughter resulting in septic shock and emphysematous pyelonephritis. J. Clin. Microbiol. 47:3780-3782.
3. Hannah, E. L., et al. 2005. Drug-resistant E. coli, rural Idaho. Emerg. Infect. Dis. 11:1614-1617.
4. Johnson, J. R., J. T. Anderson, C. Clabots, B. Johnston, and M. Cooperstock. 2010. Within-household sharing of a fluoroquinolone-resistant Escherichia coli sequence type ST131 strain causing pediatric osteoarticular infection. Pediatr. Infect. Dis. J. 29:474-475.
5. Johnson, J. R., B. Johnston, C. Clabots, M. A. Kuskowski, and M. Castanheira. 2010. Escherichia coli sequence type ST131 as the major cause of serious multidrug-resistant E. coli infections in the United States. Clin. Infect. Dis. 51:286-294.
6. Johnson, J. R., et al. 2010. Escherichia coli sequence type ST131 as an emerging fluoroquinolone-resistant uropathogen among renal transplant recipients Antimicrob. Agents Chemother. 54:546-550.
7. Johnson, J. R., et al. 2009. Epidemic clonal groups of Escherichia coli as a cause of antimicrobial-resistant urinary tract infections in Canada, 2002- 2004. Antimicrob. Agents Chemother. 53:2733-2739.
8. Johnson, J. R., S. Miller, B. Johnston, C. Clabots, and C. DebRoy. 2009. Sharing of Escherichia coli sequence type ST131 and other multidrug-resistant and urovirulent E. coli strains among dogs and cats within a household. J. Clin. Microbiol. 47:3721-3725.
9. Johnson, J. R., et al. 2005. Distribution and characteristics of Escherichia coli clonal group A. Emerg. Infect. Dis. 11:141-145.
10. Johnson, L., et al. 2008. Emergence of fluoroquinolone resistance in outpatient urinary Escherichia coli isolates. Am. J. Med. 121:876-884.
11. Lodise, T. P. J., et al. 2007. Predictors of 30-day mortality among patients with Pseudomonas aeruginosa bloodstream infections: impact of delayed appropriate antibiotic selection. Antimicrob. Agents Chemother. 51:3510-3515.
12. Peirano, G., and J. D. D. Pitout. 2010. Molecular epidemiology of Escherichia coli producing CTX-M β-lactamases: the worldwide emergence of clone ST131 O25:H4. Int. J. Antimicrob. Agents. 35:316-321.
13. Rogers, B. A., H. E. Sidjabat, and D. L. Paterson. 2011. Escherichia coli O25b-ST131: a pandemic, multiresistant, community-associated strain. J. Antimicrob. Chemother. 66:1-14.
14. Tenover, F. C., et al. 1995. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J. Clin. Microbiol. 33:2233-2239.